Journal article
Monitoring Unfractionated Heparin (UFH) therapy: Which Anti Factor Xa assay is appropriate?
Abstract
INTRODUCTION: Anti-Factor Xa (Anti-Xa) assays specifically determine the anticoagulant activity of UFH by measuring the ability of heparin-bound Antithrombin (AT) to inhibit a single enzyme, Factor Xa (FXa). Recent improvements in the automation, cost-effectiveness and accessibility of the assay to clinicians, have resulted in the Anti-Xa assay becoming a part of daily clinical practice in many institutions.
OBJECTIVES: We hypothesized that …
Authors
Ignjatovic V; Summerhayes R; Gan A; Than J; Chan A; Cochrane A; Bennett M; Horton S; Shann F; Lane G
Journal
Thrombosis Research, Vol. 120, No. 3, pp. 347–351
Publisher
Elsevier
Publication Date
January 2007
DOI
10.1016/j.thromres.2006.10.006
ISSN
0049-3848